Editorial | Segurança e eficácia de antivirais contra SARS-CoV-2 – “Precisamos de evidências, não de otimismo.”
1 Nov, 2021 | 11:02hSafety and efficacy of antivirals against SARS-CoV-2 – The BMJ
Comentário no Twitter
"Effective antivirals have an obvious appeal, but this must not cloud objective and transparent decision making." @dpsg108 and colleagues on the government's stockpiling of molnupiravir and PF-07321332+ritonavir for covid-19https://t.co/JUj1Y9op3P
— The BMJ (@bmj_latest) October 28, 2021